Segments of business and geographic areas - Sales By Segment Of Business (Details) - USD ($)
$ in Millions |
3 Months Ended |
6 Months Ended |
Jun. 28, 2026 |
Jun. 29, 2025 |
Jun. 28, 2026 |
Jun. 29, 2025 |
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 25,310
|
$ 23,743
|
$ 49,372
|
$ 45,636
|
| Percent Change (as a percent) |
6.60%
|
|
8.20%
|
|
| U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 14,533
|
13,544
|
$ 27,863
|
25,849
|
| Percent Change (as a percent) |
7.30%
|
|
7.80%
|
|
| International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 10,777
|
10,199
|
$ 21,509
|
19,787
|
| Percent Change (as a percent) |
5.70%
|
|
8.70%
|
|
| Innovative Medicine |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 16,384
|
$ 15,202
|
$ 31,810
|
$ 29,075
|
| Percent Change (as a percent) |
7.80%
|
|
9.40%
|
|
| Innovative Medicine | Change in Accounting Method Accounted for as Change in Estimate |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Adjustments To Revenue Recognized, Percent |
3.00%
|
2.60%
|
3.80%
|
3.50%
|
| Innovative Medicine | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 9,979
|
$ 9,161
|
$ 18,850
|
$ 17,253
|
| Percent Change (as a percent) |
8.90%
|
|
9.30%
|
|
| Innovative Medicine | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 6,405
|
6,041
|
$ 12,960
|
11,822
|
| Percent Change (as a percent) |
6.00%
|
|
9.60%
|
|
| Innovative Medicine | Oncology |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 7,406
|
6,312
|
$ 14,379
|
11,990
|
| Percent Change (as a percent) |
17.30%
|
|
19.90%
|
|
| Innovative Medicine | Oncology | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 4,069
|
3,385
|
$ 7,684
|
6,398
|
| Percent Change (as a percent) |
20.30%
|
|
20.10%
|
|
| Innovative Medicine | Oncology | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 3,337
|
2,928
|
$ 6,695
|
5,592
|
| Percent Change (as a percent) |
14.00%
|
|
19.70%
|
|
| Innovative Medicine | Oncology | DARZALEX |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 4,207
|
3,539
|
$ 8,171
|
6,776
|
| Percent Change (as a percent) |
18.90%
|
|
20.60%
|
|
| Innovative Medicine | Oncology | DARZALEX | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 2,435
|
2,017
|
$ 4,643
|
3,846
|
| Percent Change (as a percent) |
20.70%
|
|
20.70%
|
|
| Innovative Medicine | Oncology | DARZALEX | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,772
|
1,521
|
$ 3,528
|
2,930
|
| Percent Change (as a percent) |
16.40%
|
|
20.40%
|
|
| Innovative Medicine | Oncology | CARVYKTI |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 657
|
439
|
$ 1,254
|
808
|
| Percent Change (as a percent) |
49.40%
|
|
55.10%
|
|
| Innovative Medicine | Oncology | CARVYKTI | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 472
|
358
|
$ 905
|
676
|
| Percent Change (as a percent) |
31.70%
|
|
33.80%
|
|
| Innovative Medicine | Oncology | CARVYKTI | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 185
|
81
|
$ 349
|
132
|
| Innovative Medicine | Oncology | Tecvayli |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 260
|
166
|
$ 462
|
317
|
| Percent Change (as a percent) |
56.50%
|
|
45.50%
|
|
| Innovative Medicine | Oncology | Tecvayli | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 186
|
114
|
$ 313
|
219
|
| Percent Change (as a percent) |
63.90%
|
|
43.10%
|
|
| Innovative Medicine | Oncology | Tecvayli | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 74
|
52
|
$ 148
|
98
|
| Percent Change (as a percent) |
40.70%
|
|
51.10%
|
|
| Innovative Medicine | Oncology | TALVEY |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 174
|
106
|
$ 326
|
192
|
| Percent Change (as a percent) |
63.30%
|
|
69.30%
|
|
| Innovative Medicine | Oncology | TALVEY | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 112
|
82
|
$ 213
|
150
|
| Percent Change (as a percent) |
36.20%
|
|
41.70%
|
|
| Innovative Medicine | Oncology | TALVEY | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 62
|
24
|
$ 113
|
42
|
| Innovative Medicine | Oncology | RYBREVANT + LAZCLUZE |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 289
|
179
|
$ 546
|
320
|
| Percent Change (as a percent) |
60.80%
|
|
70.40%
|
|
| Innovative Medicine | Oncology | RYBREVANT + LAZCLUZE | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 190
|
139
|
$ 365
|
252
|
| Percent Change (as a percent) |
36.80%
|
|
45.00%
|
|
| Innovative Medicine | Oncology | RYBREVANT + LAZCLUZE | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 99
|
41
|
$ 181
|
69
|
| Innovative Medicine | Oncology | ERLEADA |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 995
|
908
|
$ 1,944
|
1,679
|
| Percent Change (as a percent) |
9.50%
|
|
15.80%
|
|
| Innovative Medicine | Oncology | ERLEADA | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 396
|
378
|
$ 738
|
670
|
| Percent Change (as a percent) |
4.70%
|
|
10.20%
|
|
| Innovative Medicine | Oncology | ERLEADA | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 599
|
530
|
$ 1,206
|
1,009
|
| Percent Change (as a percent) |
12.90%
|
|
19.40%
|
|
| Innovative Medicine | Oncology | IMBRUVICA |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 599
|
735
|
$ 1,259
|
1,444
|
| Percent Change (as a percent) |
(18.60%)
|
|
(12.90%)
|
|
| Innovative Medicine | Oncology | IMBRUVICA | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 149
|
239
|
$ 292
|
474
|
| Percent Change (as a percent) |
(37.60%)
|
|
(38.40%)
|
|
| Innovative Medicine | Oncology | IMBRUVICA | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 449
|
496
|
$ 966
|
970
|
| Percent Change (as a percent) |
(9.50%)
|
|
(0.40%)
|
|
| Innovative Medicine | Oncology | Other Oncology |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 226
|
238
|
$ 418
|
452
|
| Percent Change (as a percent) |
(4.60%)
|
|
(7.40%)
|
|
| Innovative Medicine | Oncology | Other Oncology | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 131
|
56
|
$ 216
|
110
|
| Percent Change (as a percent) |
|
|
94.50%
|
|
| Innovative Medicine | Oncology | Other Oncology | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 97
|
181
|
$ 203
|
341
|
| Percent Change (as a percent) |
(46.50%)
|
|
(40.50%)
|
|
| Innovative Medicine | Immunology |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 3,844
|
3,993
|
$ 7,224
|
7,700
|
| Percent Change (as a percent) |
(3.70%)
|
|
(6.20%)
|
|
| Innovative Medicine | Immunology | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 2,372
|
2,505
|
$ 4,227
|
4,701
|
| Percent Change (as a percent) |
(5.30%)
|
|
(10.10%)
|
|
| Innovative Medicine | Immunology | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,473
|
1,489
|
$ 2,997
|
2,999
|
| Percent Change (as a percent) |
(1.00%)
|
|
(0.10%)
|
|
| Innovative Medicine | Immunology | Tremfya |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 2,046
|
1,186
|
$ 3,654
|
2,142
|
| Percent Change (as a percent) |
72.50%
|
|
70.60%
|
|
| Innovative Medicine | Immunology | Tremfya | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,465
|
796
|
$ 2,507
|
1,395
|
| Percent Change (as a percent) |
84.20%
|
|
79.70%
|
|
| Innovative Medicine | Immunology | Tremfya | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 581
|
391
|
$ 1,147
|
747
|
| Percent Change (as a percent) |
48.70%
|
|
53.60%
|
|
| Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 618
|
690
|
$ 1,265
|
1,349
|
| Percent Change (as a percent) |
(10.50%)
|
|
(6.20%)
|
|
| Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 260
|
305
|
$ 529
|
597
|
| Percent Change (as a percent) |
(14.60%)
|
|
(11.20%)
|
|
| Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 358
|
387
|
$ 736
|
753
|
| Percent Change (as a percent) |
(7.30%)
|
|
(2.30%)
|
|
| Innovative Medicine | Immunology | Remicade |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 338
|
455
|
$ 760
|
922
|
| Percent Change (as a percent) |
(25.80%)
|
|
(17.60%)
|
|
| Innovative Medicine | Immunology | Remicade | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 215
|
283
|
$ 484
|
597
|
| Percent Change (as a percent) |
(24.10%)
|
|
(19.00%)
|
|
| Innovative Medicine | Immunology | Remicade | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 10
|
34
|
$ 28
|
44
|
| Percent Change (as a percent) |
(71.00%)
|
|
(37.10%)
|
|
| Innovative Medicine | Immunology | Remicade | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 112
|
138
|
$ 248
|
281
|
| Percent Change (as a percent) |
(18.40%)
|
|
(11.50%)
|
|
| Innovative Medicine | Immunology | STELARA |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 740
|
1,653
|
$ 1,396
|
3,278
|
| Percent Change (as a percent) |
(55.20%)
|
|
(57.40%)
|
|
| Innovative Medicine | Immunology | STELARA | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 336
|
1,078
|
$ 556
|
2,059
|
| Percent Change (as a percent) |
(68.80%)
|
|
(73.00%)
|
|
| Innovative Medicine | Immunology | STELARA | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 404
|
575
|
$ 839
|
1,219
|
| Percent Change (as a percent) |
(29.70%)
|
|
(31.10%)
|
|
| Innovative Medicine | Immunology | OTHER IMMUNOLOGY |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 104
|
8
|
$ 150
|
9
|
| Innovative Medicine | Immunology | OTHER IMMUNOLOGY | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
85
|
8
|
123
|
9
|
| Innovative Medicine | Immunology | OTHER IMMUNOLOGY | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
18
|
0
|
27
|
0
|
| Innovative Medicine | Infectious Diseases |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 763
|
803
|
$ 1,652
|
1,605
|
| Percent Change (as a percent) |
(5.00%)
|
|
2.90%
|
|
| Innovative Medicine | Infectious Diseases | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 300
|
320
|
$ 642
|
635
|
| Percent Change (as a percent) |
(6.30%)
|
|
1.10%
|
|
| Innovative Medicine | Infectious Diseases | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 463
|
484
|
$ 1,010
|
971
|
| Percent Change (as a percent) |
(4.10%)
|
|
4.10%
|
|
| Innovative Medicine | Infectious Diseases | EDURANT/rilpivirine |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 350
|
360
|
$ 759
|
718
|
| Percent Change (as a percent) |
(2.70%)
|
|
5.70%
|
|
| Innovative Medicine | Infectious Diseases | EDURANT/rilpivirine | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 3
|
6
|
$ 10
|
14
|
| Percent Change (as a percent) |
(49.60%)
|
|
(29.30%)
|
|
| Innovative Medicine | Infectious Diseases | EDURANT/rilpivirine | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 347
|
354
|
$ 749
|
704
|
| Percent Change (as a percent) |
(1.90%)
|
|
6.40%
|
|
| Innovative Medicine | Infectious Diseases | PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 372
|
396
|
$ 815
|
799
|
| Percent Change (as a percent) |
(6.30%)
|
|
1.90%
|
|
| Innovative Medicine | Infectious Diseases | PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 296
|
312
|
$ 630
|
617
|
| Percent Change (as a percent) |
(5.10%)
|
|
2.10%
|
|
| Innovative Medicine | Infectious Diseases | PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 76
|
85
|
$ 185
|
183
|
| Percent Change (as a percent) |
(10.40%)
|
|
1.20%
|
|
| Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 41
|
47
|
$ 78
|
88
|
| Percent Change (as a percent) |
(11.60%)
|
|
(11.10%)
|
|
| Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1
|
2
|
$ 2
|
4
|
| Percent Change (as a percent) |
(47.90%)
|
|
(51.60%)
|
|
| Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 40
|
45
|
$ 76
|
84
|
| Percent Change (as a percent) |
(9.60%)
|
|
(9.00%)
|
|
| Innovative Medicine | Neuroscience |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 2,337
|
2,051
|
$ 4,512
|
3,698
|
| Percent Change (as a percent) |
14.00%
|
|
22.00%
|
|
| Innovative Medicine | Neuroscience | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,659
|
1,377
|
$ 3,153
|
2,345
|
| Percent Change (as a percent) |
20.50%
|
|
34.50%
|
|
| Innovative Medicine | Neuroscience | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 678
|
674
|
$ 1,359
|
1,353
|
| Percent Change (as a percent) |
0.60%
|
|
0.40%
|
|
| Innovative Medicine | Neuroscience | SPRAVATO |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 584
|
414
|
$ 1,052
|
734
|
| Percent Change (as a percent) |
40.80%
|
|
43.20%
|
|
| Innovative Medicine | Neuroscience | SPRAVATO | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 514
|
366
|
$ 920
|
642
|
| Percent Change (as a percent) |
40.70%
|
|
43.40%
|
|
| Innovative Medicine | Neuroscience | SPRAVATO | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 70
|
50
|
$ 131
|
93
|
| Percent Change (as a percent) |
41.20%
|
|
41.80%
|
|
| Innovative Medicine | Neuroscience | CAPLYTA |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 361
|
211
|
$ 631
|
211
|
| Percent Change (as a percent) |
70.90%
|
|
|
|
| Innovative Medicine | Neuroscience | CAPLYTA | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 361
|
211
|
631
|
211
|
| Percent Change (as a percent) |
70.90%
|
|
|
|
| Innovative Medicine | Neuroscience | CAPLYTA | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 0
|
0
|
$ 0
|
0
|
| Percent Change (as a percent) |
0.00%
|
|
0.00%
|
|
| Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,015
|
992
|
$ 2,053
|
1,895
|
| Percent Change (as a percent) |
2.30%
|
|
8.40%
|
|
| Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 738
|
732
|
$ 1,496
|
1,357
|
| Percent Change (as a percent) |
0.80%
|
|
10.20%
|
|
| Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 278
|
260
|
$ 558
|
537
|
| Percent Change (as a percent) |
6.60%
|
|
3.70%
|
|
| Innovative Medicine | Neuroscience | CONCERTA/Methylphenidate |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 146
|
164
|
$ 282
|
312
|
| Percent Change (as a percent) |
(10.80%)
|
|
(9.50%)
|
|
| Innovative Medicine | Neuroscience | CONCERTA/Methylphenidate | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 12
|
24
|
$ 34
|
62
|
| Percent Change (as a percent) |
(48.60%)
|
|
(45.50%)
|
|
| Innovative Medicine | Neuroscience | CONCERTA/Methylphenidate | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 133
|
139
|
$ 248
|
249
|
| Percent Change (as a percent) |
(4.20%)
|
|
(0.40%)
|
|
| Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 232
|
270
|
$ 494
|
547
|
| Percent Change (as a percent) |
(14.00%)
|
|
(9.60%)
|
|
| Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 34
|
45
|
$ 72
|
73
|
| Percent Change (as a percent) |
(22.90%)
|
|
(1.10%)
|
|
| Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 198
|
226
|
$ 422
|
474
|
| Percent Change (as a percent) |
(12.30%)
|
|
(10.90%)
|
|
| Innovative Medicine | Pulmonary Hypertension |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,143
|
1,113
|
$ 2,278
|
2,138
|
| Percent Change (as a percent) |
2.60%
|
|
6.50%
|
|
| Innovative Medicine | Pulmonary Hypertension | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 814
|
799
|
$ 1,645
|
1,543
|
| Percent Change (as a percent) |
1.80%
|
|
6.50%
|
|
| Innovative Medicine | Pulmonary Hypertension | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 329
|
314
|
$ 633
|
595
|
| Percent Change (as a percent) |
4.90%
|
|
6.40%
|
|
| Innovative Medicine | Pulmonary Hypertension | UPTRAVI |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 494
|
476
|
$ 977
|
927
|
| Percent Change (as a percent) |
3.80%
|
|
5.40%
|
|
| Innovative Medicine | Pulmonary Hypertension | UPTRAVI | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 386
|
382
|
$ 771
|
747
|
| Percent Change (as a percent) |
1.00%
|
|
3.20%
|
|
| Innovative Medicine | Pulmonary Hypertension | UPTRAVI | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 108
|
94
|
$ 206
|
180
|
| Percent Change (as a percent) |
15.00%
|
|
14.70%
|
|
| Innovative Medicine | Pulmonary Hypertension | OPSUMIT/OPSYNVI |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 602
|
582
|
$ 1,208
|
1,104
|
| Percent Change (as a percent) |
3.40%
|
|
9.40%
|
|
| Innovative Medicine | Pulmonary Hypertension | OPSUMIT/OPSYNVI | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 416
|
403
|
$ 849
|
766
|
| Percent Change (as a percent) |
3.20%
|
|
10.90%
|
|
| Innovative Medicine | Pulmonary Hypertension | OPSUMIT/OPSYNVI | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 187
|
180
|
$ 359
|
339
|
| Percent Change (as a percent) |
3.90%
|
|
6.10%
|
|
| Innovative Medicine | Pulmonary Hypertension | Other |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 47
|
55
|
$ 93
|
107
|
| Percent Change (as a percent) |
(15.00%)
|
|
(13.60%)
|
|
| Innovative Medicine | Pulmonary Hypertension | Other | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 13
|
16
|
$ 25
|
31
|
| Percent Change (as a percent) |
(16.90%)
|
|
(19.00%)
|
|
| Innovative Medicine | Pulmonary Hypertension | Other | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 34
|
40
|
$ 68
|
77
|
| Percent Change (as a percent) |
(14.30%)
|
|
(11.50%)
|
|
| Innovative Medicine | Cardiovascular / Metabolism / Other |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 889
|
930
|
$ 1,765
|
1,943
|
| Percent Change (as a percent) |
(4.30%)
|
|
(9.20%)
|
|
| Innovative Medicine | Cardiovascular / Metabolism / Other | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 765
|
776
|
$ 1,499
|
1,631
|
| Percent Change (as a percent) |
(1.30%)
|
|
(8.10%)
|
|
| Innovative Medicine | Cardiovascular / Metabolism / Other | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 124
|
154
|
$ 266
|
312
|
| Percent Change (as a percent) |
(19.40%)
|
|
(14.80%)
|
|
| Innovative Medicine | Cardiovascular / Metabolism / Other | Other |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 225
|
309
|
$ 458
|
632
|
| Percent Change (as a percent) |
(27.20%)
|
|
(27.50%)
|
|
| Innovative Medicine | Cardiovascular / Metabolism / Other | Other | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 101
|
155
|
$ 192
|
320
|
| Percent Change (as a percent) |
(35.00%)
|
|
(39.90%)
|
|
| Innovative Medicine | Cardiovascular / Metabolism / Other | Other | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 124
|
154
|
$ 266
|
312
|
| Percent Change (as a percent) |
(19.40%)
|
|
(14.80%)
|
|
| Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 664
|
621
|
$ 1,306
|
1,311
|
| Percent Change (as a percent) |
7.10%
|
|
(0.30%)
|
|
| Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 664
|
621
|
$ 1,306
|
1,311
|
| Percent Change (as a percent) |
7.10%
|
|
(0.30%)
|
|
| Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 0
|
0
|
$ 0
|
0
|
| Percent Change (as a percent) |
0.00%
|
|
0.00%
|
|
| Innovative Medicine | Total PH, ID, CVM | Other |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 2,795
|
2,846
|
$ 5,694
|
5,686
|
| Percent Change (as a percent) |
(1.80%)
|
|
0.10%
|
|
| Innovative Medicine | Total PH, ID, CVM | Other | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,878
|
1,895
|
$ 3,785
|
3,809
|
| Percent Change (as a percent) |
(0.90%)
|
|
(0.60%)
|
|
| Innovative Medicine | Total PH, ID, CVM | Other | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 916
|
952
|
$ 1,909
|
1,878
|
| Percent Change (as a percent) |
(3.60%)
|
|
1.70%
|
|
| MEDTECH |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 8,926
|
8,541
|
$ 17,562
|
16,561
|
| Percent Change (as a percent) |
4.50%
|
|
6.00%
|
|
| MEDTECH | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 4,554
|
4,383
|
$ 9,013
|
8,596
|
| Percent Change (as a percent) |
3.90%
|
|
4.80%
|
|
| MEDTECH | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 4,372
|
4,158
|
$ 8,549
|
7,965
|
| Percent Change (as a percent) |
5.20%
|
|
7.30%
|
|
| MEDTECH | Cardiovascular |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 2,404
|
2,313
|
$ 4,781
|
4,416
|
| Percent Change (as a percent) |
4.00%
|
|
8.30%
|
|
| MEDTECH | Cardiovascular | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,426
|
1,364
|
$ 2,825
|
2,625
|
| Percent Change (as a percent) |
4.50%
|
|
7.60%
|
|
| MEDTECH | Cardiovascular | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 978
|
948
|
$ 1,956
|
1,790
|
| Percent Change (as a percent) |
3.20%
|
|
9.30%
|
|
| MEDTECH | ELECTROPHYSIOLOGY |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,533
|
1,468
|
$ 3,022
|
2,791
|
| Percent Change (as a percent) |
4.40%
|
|
8.30%
|
|
| MEDTECH | ELECTROPHYSIOLOGY | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 783
|
741
|
$ 1,519
|
1,425
|
| Percent Change (as a percent) |
5.80%
|
|
6.60%
|
|
| MEDTECH | ELECTROPHYSIOLOGY | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 749
|
728
|
$ 1,502
|
1,366
|
| Percent Change (as a percent) |
2.90%
|
|
10.00%
|
|
| MEDTECH | ABIOMED |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 440
|
448
|
$ 928
|
868
|
| Percent Change (as a percent) |
(2.00%)
|
|
6.80%
|
|
| MEDTECH | ABIOMED | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 342
|
360
|
$ 731
|
699
|
| Percent Change (as a percent) |
(4.80%)
|
|
4.60%
|
|
| MEDTECH | ABIOMED | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 97
|
89
|
$ 197
|
170
|
| Percent Change (as a percent) |
9.50%
|
|
16.10%
|
|
| MEDTECH | Shockwave |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 335
|
292
|
$ 640
|
550
|
| Percent Change (as a percent) |
14.60%
|
|
16.40%
|
|
| MEDTECH | Shockwave | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 268
|
233
|
$ 510
|
439
|
| Percent Change (as a percent) |
14.60%
|
|
16.10%
|
|
| MEDTECH | Shockwave | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 67
|
58
|
$ 130
|
110
|
| Percent Change (as a percent) |
14.50%
|
|
17.70%
|
|
| MEDTECH | Other Cardiovascular |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 98
|
104
|
$ 192
|
207
|
| Percent Change (as a percent) |
(5.70%)
|
|
(7.40%)
|
|
| MEDTECH | Other Cardiovascular | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 33
|
31
|
$ 65
|
63
|
| Percent Change (as a percent) |
5.50%
|
|
3.10%
|
|
| MEDTECH | Other Cardiovascular | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 65
|
72
|
$ 127
|
144
|
| Percent Change (as a percent) |
(10.50%)
|
|
(11.90%)
|
|
| MEDTECH | Orthopaedics |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 2,418
|
2,305
|
$ 4,801
|
4,546
|
| Percent Change (as a percent) |
4.90%
|
|
5.60%
|
|
| MEDTECH | Orthopaedics | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,470
|
1,420
|
$ 2,905
|
2,804
|
| Percent Change (as a percent) |
3.50%
|
|
3.60%
|
|
| MEDTECH | Orthopaedics | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 948
|
885
|
$ 1,896
|
1,742
|
| Percent Change (as a percent) |
7.20%
|
|
8.90%
|
|
| MEDTECH | Orthopaedics | HIPS |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 441
|
421
|
$ 877
|
830
|
| Percent Change (as a percent) |
4.90%
|
|
5.70%
|
|
| MEDTECH | Orthopaedics | HIPS | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 283
|
271
|
$ 560
|
534
|
| Percent Change (as a percent) |
4.60%
|
|
4.90%
|
|
| MEDTECH | Orthopaedics | HIPS | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 158
|
150
|
$ 317
|
296
|
| Percent Change (as a percent) |
5.50%
|
|
7.20%
|
|
| MEDTECH | Orthopaedics | KNEES |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 410
|
389
|
$ 830
|
778
|
| Percent Change (as a percent) |
5.50%
|
|
6.70%
|
|
| MEDTECH | Orthopaedics | KNEES | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 228
|
226
|
$ 467
|
457
|
| Percent Change (as a percent) |
1.10%
|
|
2.20%
|
|
| MEDTECH | Orthopaedics | KNEES | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 182
|
164
|
$ 363
|
322
|
| Percent Change (as a percent) |
11.40%
|
|
13.00%
|
|
| MEDTECH | Orthopaedics | TRAUMA |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 827
|
768
|
$ 1,660
|
1,540
|
| Percent Change (as a percent) |
7.60%
|
|
7.80%
|
|
| MEDTECH | Orthopaedics | TRAUMA | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 536
|
501
|
$ 1,068
|
1,003
|
| Percent Change (as a percent) |
6.70%
|
|
6.40%
|
|
| MEDTECH | Orthopaedics | TRAUMA | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 291
|
267
|
$ 592
|
537
|
| Percent Change (as a percent) |
9.20%
|
|
10.30%
|
|
| MEDTECH | Orthopaedics | SPINE & OTHER |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 740
|
727
|
$ 1,434
|
1,398
|
| Percent Change (as a percent) |
1.80%
|
|
2.60%
|
|
| MEDTECH | Orthopaedics | SPINE & OTHER | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 423
|
422
|
$ 810
|
810
|
| Percent Change (as a percent) |
0.20%
|
|
0.00%
|
|
| MEDTECH | Orthopaedics | SPINE & OTHER | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 317
|
305
|
$ 624
|
588
|
| Percent Change (as a percent) |
4.00%
|
|
6.10%
|
|
| MEDTECH | Surgery |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 2,653
|
2,555
|
$ 5,164
|
4,951
|
| Percent Change (as a percent) |
3.90%
|
|
4.30%
|
|
| MEDTECH | Surgery | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,094
|
1,043
|
$ 2,140
|
2,045
|
| Percent Change (as a percent) |
5.00%
|
|
4.70%
|
|
| MEDTECH | Surgery | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,559
|
1,512
|
$ 3,024
|
2,906
|
| Percent Change (as a percent) |
3.10%
|
|
4.10%
|
|
| MEDTECH | Surgery | ADVANCED |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,189
|
1,164
|
$ 2,312
|
2,237
|
| Percent Change (as a percent) |
2.20%
|
|
3.40%
|
|
| MEDTECH | Surgery | ADVANCED | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 499
|
477
|
$ 976
|
934
|
| Percent Change (as a percent) |
4.70%
|
|
4.50%
|
|
| MEDTECH | Surgery | ADVANCED | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 691
|
687
|
$ 1,337
|
1,303
|
| Percent Change (as a percent) |
0.50%
|
|
2.60%
|
|
| MEDTECH | Surgery | GENERAL |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,464
|
1,391
|
$ 2,852
|
2,714
|
| Percent Change (as a percent) |
5.20%
|
|
5.10%
|
|
| MEDTECH | Surgery | GENERAL | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 596
|
567
|
$ 1,165
|
1,111
|
| Percent Change (as a percent) |
5.20%
|
|
4.80%
|
|
| MEDTECH | Surgery | GENERAL | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 868
|
825
|
$ 1,687
|
1,603
|
| Percent Change (as a percent) |
5.30%
|
|
5.20%
|
|
| MEDTECH | Vision |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,451
|
1,369
|
$ 2,816
|
2,648
|
| Percent Change (as a percent) |
6.00%
|
|
6.30%
|
|
| MEDTECH | Vision | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 565
|
557
|
$ 1,144
|
1,123
|
| Percent Change (as a percent) |
1.40%
|
|
1.90%
|
|
| MEDTECH | Vision | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 887
|
813
|
$ 1,672
|
1,526
|
| Percent Change (as a percent) |
9.10%
|
|
9.60%
|
|
| MEDTECH | Vision | CONTACT LENSES / OTHER |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 1,025
|
965
|
$ 1,994
|
1,884
|
| Percent Change (as a percent) |
6.10%
|
|
5.80%
|
|
| MEDTECH | Vision | CONTACT LENSES / OTHER | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 445
|
429
|
$ 913
|
881
|
| Percent Change (as a percent) |
3.60%
|
|
3.70%
|
|
| MEDTECH | Vision | CONTACT LENSES / OTHER | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 580
|
536
|
$ 1,081
|
1,003
|
| Percent Change (as a percent) |
8.10%
|
|
7.70%
|
|
| MEDTECH | Vision | SURGICAL |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 426
|
403
|
$ 822
|
764
|
| Percent Change (as a percent) |
5.60%
|
|
7.50%
|
|
| MEDTECH | Vision | SURGICAL | U.S. |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 120
|
128
|
$ 231
|
242
|
| Percent Change (as a percent) |
(6.00%)
|
|
(4.50%)
|
|
| MEDTECH | Vision | SURGICAL | International |
|
|
|
|
| Sales by segment of business |
|
|
|
|
| Sales to customers |
$ 306
|
$ 277
|
$ 591
|
$ 523
|
| Percent Change (as a percent) |
10.90%
|
|
13.10%
|
|